SCHEMBL8178337

SCHEMBL8178337

N#CCN1CCC(C(=O)O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP2C19 P33261 1/20 0.37
PLG P00747 1/20 0.36
PLAT P00750 1/20 0.36
BCHE P06276 1/20 0.36
LTA4H P09960 2/20 0.36
POLB P06746 1/20 0.36
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7291983 0.82 L3MBTL1 (0.41) L3MBTL1SMN1; SMN2LMNATSHRKDM4E
SCHEMBL13891403 0.82 BCHE (0.51) L3MBTL1SMN1; SMN2BCHENPC1RAB9A
SCHEMBL18130834 0.78 KDM2B (0.50) LMNATSHRCYP2C19
SCHEMBL13956309 0.77 SMN1; SMN2 (0.39) L3MBTL1SMN1; SMN2LMNAKDM4EBCHE
SCHEMBL19514340 0.76 LTA4H (0.47) L3MBTL1SMN1; SMN2LMNATSHRKDM4E
SCHEMBL16050255 0.76 SMN1; SMN2 (0.42) L3MBTL1SMN1; SMN2LMNAKDM4EBCHE
SCHEMBL14456689 0.75 MAPT (0.56) SMN1; SMN2LMNAKDM4E
SCHEMBL11174725 0.74 KDM4E (0.36) L3MBTL1SMN1; SMN2LMNATSHRKDM4E
SCHEMBL1052748 0.74 HRH3 (0.47) SMN1; SMN2TSHR
SCHEMBL3897207 0.74 GPR119 (0.50) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084610-B2 Compositions and methods for detecting and treating tumors containing acidic areas SUMMERTON JAMES EDWARD (US) 2011-12-27 US disclosed
US-20080124274-A1 Compositions and methods for detecting and treating tumors containing acidic areas SUMMERTON JAMES EDWARD 2008-05-29 US disclosed
US-20070286803-A1 Compositions and methods for detecting and treating tumors containing acidic areas SUMMERTON JAMES EDWARD 2007-12-13 US disclosed
US-20070231256-A1 Compositions and methods for detecting and treating tumors containing acidic areas SUMMERTON JAMES E 2007-10-04 US disclosed
US-6090825-A Oxazole derivatives as antagonists of alpha 1C andrenergic receptors GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
EP-0793658-A1 OXAZOLE DERIVATIVES AS ANTAGONISTS OF ALPHA-1C ADRENERGIC RECEPTORS GLAXO WELLCOME INC. (US) 1997-09-10 EP disclosed
WO-1996016049-A1 OXAZOLE DERIVATIVES AS ANTAGONISTS OF α-1C ADRENERGIC RECEPTORS GLAXO WELLCOME INC. (US) 1996-05-30 WO disclosed